Skip to main content
. 2018 Jun 1;8(6):1040–1049.

Figure 6.

Figure 6

Impact of SBP1 and CXCR4 expression on HCC patient survival. A. Kaplan-Meier survival curves show that patients with negative expression of SBP1 in tumor cells experienced shorter overall survival (OS) periods (P=0.005) and higher recurrence rates (P=0.047) than patients with positive expression of SBP1. B. Kaplan-Meier survival curves show that patients with positive expression of CXCR4 in tumor cells experienced shorter OS periods (P=0.04) and higher recurrence rates (P=0.015) than patients with negative expression of CXCR4. C. HCC patients co-expressing negative expression of SBP1 and positive expression of CXCR4 had the poorest prognosis in terms of OS (P=0.002) and cumulative recurrence rate (P<0.001).